Latest Articles
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - The Manila Times
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights The Manila Times
Published: Aug. 13, 2025, 8:31 p.m.
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights - GlobeNewswire
Acrivon Therapeutics Reports Second Quarter 2025 Financial Results and Business Highlights GlobeNewswire
Published: Aug. 13, 2025, 8:17 p.m.
Karyopharm Therapeutics Inc. SEC 10-Q Report - TradingView
Karyopharm Therapeutics Inc. SEC 10-Q Report TradingView
Published: Aug. 11, 2025, 11:43 a.m.
Lisata Therapeutics Q2 2025: Key Contradictions in ASCEND Trial Insights and Financial Projections - AInvest
Lisata Therapeutics Q2 2025: Key Contradictions in ASCEND Trial Insights and Financial Projections AInvest
Published: Aug. 8, 2025, 7:14 a.m.
Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer - TipRanks
Iovance Biotherapeutics Advances Lifileucel Study for Endometrial Cancer TipRanks
Published: Aug. 7, 2025, 4:18 p.m.
Onconic Therapeutics announced on the 28th that "Nesuparib," a candidate for a double-targeted antic.. - 매일경제
Onconic Therapeutics announced on the 28th that "Nesuparib," a candidate for a double-targeted antic.. 매일경제
Published: July 28, 2025, 6:56 a.m.
Universal Quantum Joins Institute To Advance Endometrius Therapeutics - Quantum Zeitgeist
Universal Quantum Joins Institute To Advance Endometrius Therapeutics Quantum Zeitgeist
Published: July 24, 2025, 11:09 a.m.
Endometriosis Therapeutics: A Market in Need, but Can Organon Still Lead? - AInvest
Endometriosis Therapeutics: A Market in Need, but Can Organon Still Lead? AInvest
Published: July 2, 2025, 1:04 p.m.
Womens Health Therapeutics Market to Reach USD 61.6 Billion by 2032, Driven by Innovation - newstrail.com
Womens Health Therapeutics Market to Reach USD 61.6 Billion by 2032, Driven by Innovation newstrail.com
Published: July 1, 2025, 10:45 a.m.
Women's Health Therapeutics Market Revenue to Attain USD 64.04 Bn by 2033 - Precedence Research
Women's Health Therapeutics Market Revenue to Attain USD 64.04 Bn by 2033 Precedence Research
Published: June 13, 2025, 1:43 p.m.
Link copied to clipboard!